The endocytic recycling compartment serves as a viral factory for hepatitis E virus.

AlphaFold2 Antibodies Electron microscopy Endocytic recycling compartment Hepatitis E virus Infectious particles ORF2 capsid protein Rab11 Viral factories

Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
03 Dec 2022
Historique:
received: 26 08 2022
accepted: 23 11 2022
revised: 04 11 2022
entrez: 2 12 2022
pubmed: 3 12 2022
medline: 7 12 2022
Statut: epublish

Résumé

Although hepatitis E virus (HEV) is the major leading cause of enterically transmitted viral hepatitis worldwide, many gaps remain in the understanding of the HEV lifecycle. Notably, viral factories induced by HEV have not been documented yet, and it is currently unknown whether HEV infection leads to cellular membrane modeling as many positive-strand RNA viruses. HEV genome encodes the ORF1 replicase, the ORF2 capsid protein and the ORF3 protein involved in virion egress. Previously, we demonstrated that HEV produces different ORF2 isoforms including the virion-associated ORF2i form. Here, we generated monoclonal antibodies that specifically recognize the ORF2i form and antibodies that recognize the different ORF2 isoforms. One antibody, named P1H1 and targeting the ORF2i N-terminus, recognized delipidated HEV particles from cell culture and patient sera. Importantly, AlphaFold2 modeling demonstrated that the P1H1 epitope is exposed on HEV particles. Next, antibodies were used to probe viral factories in HEV-producing/infected cells. By confocal microscopy, we identified subcellular nugget-like structures enriched in ORF1, ORF2 and ORF3 proteins and viral RNA. Electron microscopy analyses revealed an unprecedented HEV-induced membrane network containing tubular and vesicular structures. We showed that these structures are dependent on ORF2i capsid protein assembly and ORF3 expression. An extensive colocalization study of viral proteins with subcellular markers, and silencing experiments demonstrated that these structures are derived from the endocytic recycling compartment (ERC) for which Rab11 is a central player. Hence, HEV hijacks the ERC and forms a membrane network of vesicular and tubular structures that might be the hallmark of HEV infection.

Identifiants

pubmed: 36460928
doi: 10.1007/s00018-022-04646-y
pii: 10.1007/s00018-022-04646-y
pmc: PMC9718719
doi:

Substances chimiques

Capsid Proteins 0
Antibodies, Monoclonal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

615

Subventions

Organisme : Inserm Transfert
ID : MAT-PI-17006
Organisme : Institut Pasteur de Lille
ID : DiagHepE
Organisme : Région Hauts-de-France
ID : DiagHepE

Informations de copyright

© 2022. The Author(s).

Références

Kamar N, Izopet J, Pavio N et al (2017) Hepatitis E virus infection. Nat Rev Dis Primers 3:17086. https://doi.org/10.1111/trf.13355
doi: 10.1111/trf.13355
Doceul V, Bagdassarian E, Demange A, Pavio N (2016) Zoonotic hepatitis E virus: classification animal reservoirs and transmission routes. Viruses 8:270. https://doi.org/10.3390/v8100270
doi: 10.3390/v8100270
Horvatits T, Wiesch JS, zur, Lütgehetmann M, et al (2019) The clinical perspective on hepatitis E. Viruses 11:617–619. https://doi.org/10.3390/v11070617
doi: 10.3390/v11070617
Lee G-H, Tan B-H, Teo EC-Y et al (2016) Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology 150:355–7.e3. https://doi.org/10.1053/j.gastro.2015.10.048
doi: 10.1053/j.gastro.2015.10.048
Aslan AT, Balaban HY (2020) Hepatitis E virus: epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroentero 26:5543–5560. https://doi.org/10.3748/wjg.v26.i37.5543
doi: 10.3748/wjg.v26.i37.5543
Nimgaonkar I, Ding Q, Schwartz RE, Ploss A (2018) Hepatitis E virus: advances and challenges. Nat Rev Gastroenterol Hepatol 15:96–110. https://doi.org/10.1038/nrgastro.2017.150
doi: 10.1038/nrgastro.2017.150
Montpellier C, Wychowski C, Sayed IM et al (2018) Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein. Gastroenterology 154:211-223.e8. https://doi.org/10.1053/j.gastro.2017.09.020
doi: 10.1053/j.gastro.2017.09.020
Yin X, Ying D, Lhomme S et al (2018) Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection. Proc Natl Acad Sci USA 3:201721345–201721346. https://doi.org/10.1073/pnas.1721345115
doi: 10.1073/pnas.1721345115
Sayed IM, Verhoye L, Montpellier C et al (2019) Hepatitis E virus (HEV) open reading frame 2 antigen kinetics in human-liver chimeric mice and its impact on HEV diagnosis. J Infect Dis 220:811–819. https://doi.org/10.1093/infdis/jiz171
doi: 10.1093/infdis/jiz171
Hervouet K, Ferrié M, Ankavay M et al (2022) An arginine-rich motif in the ORF2 capsid protein regulates the hepatitis e virus lifecycle and interactions with the host cell. PLoS Pathog 18:e1010798. https://doi.org/10.1371/journal.ppat.1010798
doi: 10.1371/journal.ppat.1010798
Meister TL, Bruening J, Todt D, Steinmann E (2019) Cell culture systems for the study of hepatitis E virus. Antiviral Res 163:34–49. https://doi.org/10.1016/j.antiviral.2019.01.007
doi: 10.1016/j.antiviral.2019.01.007
Ju X, Ding Q (2019) Hepatitis E virus assembly and release. Viruses 11:539–613. https://doi.org/10.3390/v11060539
doi: 10.3390/v11060539
Harak C, Lohmann V (2015) Ultrastructure of the replication sites of positive-strand RNA viruses. Virology 479:418–433. https://doi.org/10.1016/j.virol.2015.02.029
doi: 10.1016/j.virol.2015.02.029
Talmont F, Moulédous L, Baranger M et al (2019) Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors. PLoS ONE 14:e0213203-e213219. https://doi.org/10.1371/journal.pone.0213203
doi: 10.1371/journal.pone.0213203
Graff J, Nguyen H, Yu C et al (2005) The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol 79:6680–6689. https://doi.org/10.1128/jvi.79.11.6680-6689.2005
doi: 10.1128/jvi.79.11.6680-6689.2005
Flint M, Maidens C, Loomis-Price LD et al (1999) Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73:6235–6244
doi: 10.1128/JVI.73.8.6235-6244.1999
Oren R, Takahashi S, Doss C et al (1990) TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 10:4007. https://doi.org/10.1128/mcb.10.8.4007
doi: 10.1128/mcb.10.8.4007
Blight KJ, Mckeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76:13001–13014. https://doi.org/10.1128/jvi.76.24.13001-13014.2002
doi: 10.1128/jvi.76.24.13001-13014.2002
Ankavay M, Montpellier C, Sayed IM et al (2019) New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle. Sci Rep 9:6243. https://doi.org/10.1038/s41598-019-42737-2
doi: 10.1038/s41598-019-42737-2
Shukla P, Nguyen HT, Faulk K et al (2012) Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol 86:5697–5707. https://doi.org/10.1128/jvi.00146-12
doi: 10.1128/jvi.00146-12
Metzger K, Bentaleb C, Hervouet K et al (2022) Processing and subcellular localization of the hepatitis E virus replicase: identification of candidate viral factories. Front Microbiol 13:828636. https://doi.org/10.3389/fmicb.2022.828636
doi: 10.3389/fmicb.2022.828636
Jothikumar N, Cromeans TL, Robertson BH et al (2006) A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 131:65–71. https://doi.org/10.1016/j.jviromet.2005.07.004
doi: 10.1016/j.jviromet.2005.07.004
Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589. https://doi.org/10.1038/s41586-021-03819-2
doi: 10.1038/s41586-021-03819-2
Gabler F, Nam S, Till S et al (2020) Protein sequence analysis using the MPI bioinformatics toolkit. Curr Protoc Bioinform 72:e108. https://doi.org/10.1002/cpbi.108
doi: 10.1002/cpbi.108
Xing L, Li TC, Mayazaki N et al (2010) Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 285:33175–33183. https://doi.org/10.1074/jbc.m110.106336
doi: 10.1074/jbc.m110.106336
Wang F, Flanagan J, Su N et al (2012) RNAscope a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14:22–29. https://doi.org/10.1016/j.jmoldx.2011.08.002
doi: 10.1016/j.jmoldx.2011.08.002
Liu D, Tedbury PR, Lan S et al (2019) Visualization of positive and negative sense viral RNA for probing the mechanism of direct-acting antivirals against hepatitis C virus. Viruses 11:1039. https://doi.org/10.3390/v11111039
doi: 10.3390/v11111039
Ding Q, Heller B, Capuccino JMV et al (2017) Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1614955114
doi: 10.1073/pnas.1614955114
Nagashima S, Jirintai S, Takahashi M et al (2014) Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. J Gen Virol 95:2166–2175. https://doi.org/10.1099/vir.0.066910-0
doi: 10.1099/vir.0.066910-0
Nagashima S, Takahashi M, Jirintai, et al (2011) A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J Gen Virol 92:269–278. https://doi.org/10.1099/vir.0.025791-0
doi: 10.1099/vir.0.025791-0
Gouttenoire J, Pollán A, Abrami L et al (2018) Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion. PLoS Pathog 14:e1007471–e1007524. https://doi.org/10.1371/journal.ppat.1007471
doi: 10.1371/journal.ppat.1007471
Lombardi D, Soldati T, Riederer MA et al (1993) Rab9 functions in transport between late endosomes and the trans Golgi network. Embo J 12:677–682. https://doi.org/10.1002/j.1460-2075.1993.tb05701.x
doi: 10.1002/j.1460-2075.1993.tb05701.x
Hutagalung AH, Novick PJ (2011) Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 91:119–149. https://doi.org/10.1152/physrev.00059.2009
doi: 10.1152/physrev.00059.2009
Maxfield FR, McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5:121–132. https://doi.org/10.1038/nrm1315
doi: 10.1038/nrm1315
Vale-Costa S, Amorim M (2016) Recycling endosomes and viral infection. Viruses 8:29–64. https://doi.org/10.3390/v8030064
doi: 10.3390/v8030064
Ullrich O, Reinsch S, Urbé S et al (1996) Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biology 135:913–924. https://doi.org/10.1083/jcb.135.4.913
doi: 10.1083/jcb.135.4.913
Stone R, Hayashi T, Bajimaya S et al (2016) Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses. Virology 487:11–18. https://doi.org/10.1016/j.virol.2015.10.008
doi: 10.1016/j.virol.2015.10.008
Bhuin T, Roy JK (2015) Rab11 in disease progression. Int J Mol Cell Med 4:1–8
Guichard A, Nizet V, Bier E (2014) RAB11-mediated trafficking in host–pathogen interactions. Nat Rev Microbiol 12:624–634. https://doi.org/10.1038/nrmicro3325
doi: 10.1038/nrmicro3325
Mayle KM, Le AM, Kamei DT (2012) The intracellular trafficking pathway of transferrin. Biochimica et Biophysica Acta BBA 1820:264–281. https://doi.org/10.1016/j.bbagen.2011.09.009
doi: 10.1016/j.bbagen.2011.09.009
Hehnly H, Chen C-T, Powers CM et al (2012) The centrosome regulates the Rab11- dependent recycling endosome pathway at appendages of the mother centriole. Curr Biol 22:1944–1950. https://doi.org/10.1016/j.cub.2012.08.022
doi: 10.1016/j.cub.2012.08.022
Yang Y-L, Nan Y-C (2021) Open reading frame 3 protein of hepatitis E virus: multi-function protein with endless potential. World J Gastroenterol 27:2458–2473. https://doi.org/10.3748/wjg.v27.i20.2458
doi: 10.3748/wjg.v27.i20.2458
Nagashima S, Takahashi M, Kobayashi T et al (2017) Characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway. J Virol. https://doi.org/10.1128/jvi.00822-17
doi: 10.1128/jvi.00822-17
Surjit M, Jameel S, Lal SK (2007) Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J Virol 81:3339–3345. https://doi.org/10.1128/jvi.02039-06
doi: 10.1128/jvi.02039-06
Zafrullah M, Ozdener MH, Kumar R et al (1999) Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol 73:4074–4082
doi: 10.1128/JVI.73.5.4074-4082.1999
Lenggenhager D, Gouttenoire J, Malehmir M et al (2017) Visualization of hepatitis E virus RNA and proteins in the human liver. J Hepatol 67:471–479. https://doi.org/10.1016/j.jhep.2017.04.002
doi: 10.1016/j.jhep.2017.04.002
Nagashima S, Takahashi M, Jirintai S et al (2011) Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J Gen Virol 92:2838–2848. https://doi.org/10.1099/vir.0.035378-0
doi: 10.1099/vir.0.035378-0
Chandra V, Kar-Roy A, Kumari S et al (2008) The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol 82:7100–7110. https://doi.org/10.1128/jvi.00403-08
doi: 10.1128/jvi.00403-08
Zafrullah M, Ozdener MH, Panda SK, Jameel S (1997) The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol 71:9045–9053
doi: 10.1128/jvi.71.12.9045-9053.1997
Kannan H, Fan S, Patel D et al (2009) The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. J Virol 83:6375–6382. https://doi.org/10.1128/jvi.02571-08
doi: 10.1128/jvi.02571-08
Szkolnicka D, Pollán A, Silva ND et al (2019) Recombinant hepatitis E viruses harboring tags in the ORF1 protein. J Virol 93:1237–1318. https://doi.org/10.1128/jvi.00459-19
doi: 10.1128/jvi.00459-19
Hollinshead M, Johns HL, Sayers CL et al (2012) Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J 31:4204–4220. https://doi.org/10.1038/emboj.2012.262
doi: 10.1038/emboj.2012.262
Coller KE, Heaton NS, Berger KL et al (2012) Molecular determinants and dynamics of hepatitis C virus secretion. Plos Pathog 8:e1002466. https://doi.org/10.1371/journal.ppat.1002466
doi: 10.1371/journal.ppat.1002466

Auteurs

Cyrine Bentaleb (C)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Kévin Hervouet (K)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Claire Montpellier (C)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Charline Camuzet (C)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Martin Ferrié (M)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Julien Burlaud-Gaillard (J)

Inserm U1259, Morphogénèse et Antigénicité du VIH et des Virus des Hépatites (MAVIVH), Université de Tours and CHRU de Tours, 37032, Tours, France.
Université de Tours et CHRU de Tours, Plateforme IBiSA de Microscopie Electronique, Tours, France.

Stéphane Bressanelli (S)

Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-Sur-Yvette, France.

Karoline Metzger (K)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Elisabeth Werkmeister (E)

Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR2014-US41-PLBS-Plateformes Lilloises de Biologie and Santé, Lille, France.

Maliki Ankavay (M)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.
Division of Gastroenterology and Hepatology, Institute of Microbiology, Lausanne, Switzerland.

Nancy Leon Janampa (NL)

Inserm U1259, Morphogénèse et Antigénicité du VIH et des Virus des Hépatites (MAVIVH), Université de Tours and CHRU de Tours, 37032, Tours, France.

Julien Marlet (J)

Inserm U1259, Morphogénèse et Antigénicité du VIH et des Virus des Hépatites (MAVIVH), Université de Tours and CHRU de Tours, 37032, Tours, France.

Julien Roux (J)

BIOTEM, Apprieu, France.

Clarence Deffaud (C)

BIOTEM, Apprieu, France.

Anne Goffard (A)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Yves Rouillé (Y)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Jean Dubuisson (J)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Philippe Roingeard (P)

Inserm U1259, Morphogénèse et Antigénicité du VIH et des Virus des Hépatites (MAVIVH), Université de Tours and CHRU de Tours, 37032, Tours, France.
Université de Tours et CHRU de Tours, Plateforme IBiSA de Microscopie Electronique, Tours, France.

Cécile-Marie Aliouat-Denis (CM)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France.

Laurence Cocquerel (L)

University of Lille, CNRS, Inserm, CHU Lille, Pasteur Institute of Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59000, Lille, France. laurence.cocquerel@cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH